12:00 AM
 | 
Mar 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Angel Biotech, Collbio deal

Newco Collbio acquired the assets of Angel Biotechnology's Angel Biomedical Ltd. subsidiary and said it will focus on manufacturing medical grade collagen components for the regenerative medicine, in vitro diagnostic and medical device markets. The companies...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >